New program aims to ease cancer Patients' pain and depression

NCT ID NCT07183527

Recruiting now Symptom relief Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study tests a program called CARES that provides cancer patients with integrated screening and stepped care for symptoms like pain and depression. About 1,750 adults with cancer will be randomly assigned to CARES or standard care. The goal is to see if CARES improves quality of life and reduces symptoms better than usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CARES (integrated screening and stepped collaborative care program)
What this could lead to: If successful, CARES could become a widely used program to help cancer patients feel better and manage symptoms like pain and depression.
What could go wrong: This is a behavioral intervention, not a drug or cure. Results depend on how well clinics adopt the program, and benefits may vary across patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARES STANDARD OF CARE

Contacts and locations

Locations

University of Pittsburgh Medical Center (UPMC) Cancer Center
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.